Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life

Lignende værker

• Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol
  af: Ouzaid, Idir, et al.
  Udgivet: (2013)
• High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance
  af: Ploussard, Guillaume, et al.
  Udgivet: (2009)
• Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years
  af: Liapis, Dimitri, et al.
  Udgivet: (2008)
• Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
  af: Chen, Mengqian, et al.
  Udgivet: (2010)
• Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy
  af: Ploussard, Guillaume, et al.
  Udgivet: (2010)